Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings.
Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings.
复制标题
DOI:
10.1111/j.1360-0443.2011.03700.x
复制
发表时间:
2012-05
期刊:
影响因子:
--
通讯作者:
Jaffe JH
中科院分区:
文献类型:
--
作者:
Schwartz RP;Kelly SM;O'Grady KE;Gandhi D;Jaffe JH
This study aimed to determine the relative effectiveness of 12-months of Interim Methadone (IM; supervised methadone with emergency counseling only for the first 4 months of treatment), Standard Methadone treatment (SM; with routine counseling) and Restored Methadone treatment (RM: routine counseling with smaller caseloads). A randomized controlled trial was conducted comparing: IM, SM, and RM treatment. IM lasted for 4 months after which participants were transferred to SM. The study was conducted in two methadone treatment programs in Baltimore, MD, USA. The study included 230 adult methadone patients newly-admitted through waiting lists. We administered the Addiction Severity Index and a supplemental questionnaire at baseline, 4-, and 12-months post- baseline. Measurements included retention in treatment, self-reported days of heroin and cocaine use, criminal behavior and arrests, and urine tests for heroin and cocaine metabolites. At 12 months, on an intent-to-treat basis, there were no significant differences in retention in treatment among the IM, SM and RM groups (60.6%, 54.8% and 37.8%, respectively). Positive urine tests for the three groups declined significantly from baseline (ps<0.001 and 0.003, for heroin and cocaine metabolistes respectively) but there were no significant Group x Time interactions for these measures. Thirty-one percent of the sample reported at least one arrest during the year, but there were no significant between-group effects. Limited availability of drug counseling services should not be a barrier to providing supervised methadone to adults dependent on heroin - at least for the first 4 months of treatment.
登录
查看更多内容
影响因子:
4.2
作者:
Schwartz, Robert P.;Jaffe, Jerome H.;O'Grady, Kevin E.
通讯作者:
O'Grady, Kevin E.
影响因子:
120.7
作者:
MCLELLAN, AT;ARNDT, IO;OBRIEN, CP
通讯作者:
OBRIEN, CP
影响因子:
105.7
作者:
FARRELL, M;WARD, J;STRANG, J
通讯作者:
STRANG, J
影响因子:
5.9
作者:
STITZER, ML;IGUCHI, MY;FELCH, LJ
通讯作者:
FELCH, LJ
影响因子:
2.8
作者:
Reisinger HS;Schwartz RP;Mitchell SG;Peterson JA;Kelly SM;O'Grady KE;Marrari EA;Brown BS;Agar MH
通讯作者:
Agar MH